3β-(4(5)-Imidazolyl)-5α-androstane-11β,17β-diamine, 15, has been synthesized in a multistep process from adrenosterone, 2, starting with lithium ammonia reduction to give 11α,17β-dihydroxy-5α-androstan-3-one, 3, which was converted to its diacetate, 4. Ethynylation at the 3 keto group gave the ethynyl triol 5, purified as its11,17-diacetate 6. Acid catalyzed rearrangement of 6 gave 3-acetyl-5α-androst-2-ene-11α,17β-diol diacetate, 7. This was hydrogenated, and then subjected to base catalyzed hydrolysis and equilibration to give crystalline 3β-acetyl-5α-androstane-11α,17β-diol, 9, which was converted to 3β-acetoxyacetyl-5α-androstane-11α,17β-diol, 10, using lead tetraacetate. After hydrolysis to the triol, 11, the Weidenhagen reaction led to formation of 3β-imidazolyl-5α-androstane-11α,17β-diol, 12. Finally oxidation to the dione, 13, formation of the dioxime, 14, and hydrogénation give 15. As expected 15 is a better catalyst than 17β-(4(5)-imidazolyl-5α-androstane-3β,11β-diamine, 1, for the hydrolysis of aryl esters of acids with hydrophobic substituents, but the effect is small. With 1 there is a marked electrostatic rate enhancement or retardation when charged groups are present on the aryl esters; this effect is much smaller for 15.
Read full abstract